{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:11:21Z","timestamp":1711642281434},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1212\/wnl.50.3.834","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:32:33Z","timestamp":1336915953000},"page":"834-834","source":"Crossref","is-referenced-by-count":0,"title":["Albendazole therapy for neurocysticercosis"],"prefix":"10.1212","volume":"50","author":[{"given":"David Y.","family":"Ko","sequence":"first","affiliation":[{"name":"Los Angeles, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Young-Nam Chang","sequence":"additional","affiliation":[{"name":"Los Angeles, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.1.1"},{"key":"e_1_3_1_3_2","first-page":"1","volume":"52","year":"1995","unstructured":"Kramer LD. Medical treatment of cysticercosis-Ineffective. Arch Neurol 1995;52:101-102. Letter.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_4_2","first-page":"1","volume":"52","year":"1995","unstructured":"Del Brutto OH. Medical treatment of cysticercosis-Effective. Arch Neurol 1995;52:102-104. Letter.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6614.6"},{"key":"e_1_3_1_6_2","unstructured":"Mitchell WG. Cerebral cysticercosis in North American children. In: Johnson RT Griffin JW. Current therapy in neurologic disease. 4th ed. St. Louis: Mosby Year Book 1993:123-126."},{"key":"e_1_3_1_7_2","first-page":"4","volume":"145","year":"1985","unstructured":"Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive forms; a study of 753 cases. Arch Intern Med 1985;145:442-445.","journal-title":"Arch Intern Med"},{"key":"e_1_3_1_8_2","unstructured":"Escobar A. The pathology of neurocysticercosis. In: Palacios E Rodriquez-Carbajal J Taveras JM eds. Cysticercosis of the central nervous system. Springfield: Charles C. Thomas 1983;27-54."},{"key":"e_1_3_1_9_2","first-page":"1","volume":"46","year":"1989","unstructured":"Alarc\u00f3n F, Escalante L, Due\u00f1as G, Montalvo M, Rom\u00e1n M. Neurocysticercosis: short course of treatment with albendazole. Arch Neurol 1989;46:1231-1236.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00582806"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Vazquez V Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327-696-701.","DOI":"10.1056\/NEJM199209033271005"},{"key":"e_1_3_1_12_2","first-page":"2","volume":"49","year":"1992","unstructured":"Takayanagui OM, Jardim E. Therapy for neurocysticercosis; comparison between albendazole and praziquantel. Arch Neurol 1992;49:290-294.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_13_2","first-page":"1","volume":"155","year":"1995","unstructured":"Carpio A, Santill\u00e1n F, Le\u00f3n P, Flores C, Hauser WA. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 1995;155:1982-1988.","journal-title":"Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med"},{"key":"e_1_3_1_14_2","first-page":"5","volume":"19","year":"1997","unstructured":"Takayanagui OM, Lanchote VL, Marques MPC, Bonato PS. Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone. Ther Drug Monit 1997;19:51-55.","journal-title":"Ther Drug Monit"},{"key":"e_1_3_1_15_2","first-page":"2","volume":"85","year":"1991","unstructured":"Cruz M, Cruz I, Horton J. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation. Trans R Soc Trop Med Hyg 1991;85:244-247.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(95)00186-6"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.1.1"},{"key":"e_1_3_1_18_2","first-page":"3","volume":"42","year":"1992","unstructured":"Del Brutto OH, Santiba\u00f1ez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;42:389-392.","journal-title":"Neurology"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.1.1"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.50.3.834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:45:23Z","timestamp":1711640723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.50.3.834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["10.1212\/WNL.50.3.834"],"URL":"https:\/\/doi.org\/10.1212\/wnl.50.3.834","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}